SCHEMBL5780281

SCHEMBL5780281

Clc1cc(Nc2ncnc3sc4c(c23)CCC(CCNCCN2CCOCC2)C4)ccc1OCc1ccccn1

nearest known ligand 0.56

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
EGFR P00533 16/20 0.56
ERBB2 P04626 16/20 0.55
KCNH2 Q12809 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5629707 0.95 EGFR (0.60) EGFRERBB2KCNH2
SCHEMBL5628707 0.89 EGFR (0.53) EGFRERBB2KCNH2
SCHEMBL5630035 0.89 EGFR (0.58) EGFRERBB2KCNH2
SCHEMBL5629553 0.88 EGFR (0.58) EGFRERBB2KCNH2
SCHEMBL5629571 0.88 EGFR (0.54) EGFRERBB2KCNH2
SCHEMBL5628581 0.88 ERBB2 (0.53) EGFRERBB2KCNH2
SCHEMBL5632383 0.88 EGFR (0.60) EGFRERBB2KCNH2
SCHEMBL5774457 0.88 EGFR (0.63) EGFRERBB2
SCHEMBL5630761 0.87 EGFR (0.56) EGFRERBB2KCNH2
SCHEMBL5629308 0.87 EGFR (0.55) EGFRERBB2KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7238701-B2 Substituted tetrahydrobenzothienopyrimidinamine compounds useful for treating hyper-proliferative disorders BAYER PHARMACEUTICALS CORPORATION (US) 2007-07-03 US disclosed
US-7238701-B2 Substituted tetrahydrobenzothienopyrimidinamine compounds useful for treating hyper-proliferative disorders BAYER PHARMACEUTICALS CORPORATION (US) 2007-07-03 US disclosed
EP-1651652-B1 SUBSTITUTED TETRAHYDROBENZOTHIENOPYRIMIDINAMINE COMPOUNDS USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS BAYER PHARMACEUTICALS CORP (US) 2006-12-27 EP disclosed